title: Design, synthesis and biological activity of aromatic diketone derivatives as HIV-1 integrase inhibitors.
abstract: A series of aromatic diketone derivatives were designed and synthesized as potential HIV-1 integrase (IN) inhibitors and evaluated to determine their ability to inhibit the strand transfer process of HIV-1 integrase. The results indicate that (Z)-1-(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)-3-hydroxy-3-(substituted)phenylprop-2-en-1-one (5a-5d) can moderately inhibit HIV-1 integrase. The cyclization and condensation products (6a-6c and 7e-7f) of compounds 5a-5d show poor inhibitory activity against HIV-1 integrase. The molecular docking results indicate that the different types of compounds act on HIV-1 integrase in different ways, and these results can explain the differences in the inhibitory activities.
authors.forename: Liming
authors.initials: L
authors.lastname: Hu
authors.forename: Zhipeng
authors.initials: Z
authors.lastname: Li
authors.forename: Zhanyang
authors.initials: Z
authors.lastname: Wang
authors.forename: Gengxin
authors.initials: G
authors.lastname: Liu
authors.forename: Xianzhuo
authors.initials: X
authors.lastname: He
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Wang
authors.affiliation: College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. huliming@bjut.edu.cn.
authors.forename: Chengchu
authors.initials: C
authors.lastname: Zeng
mesh_terms: D047188:Chalcones / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D003500:Cyclization; D015195:Drug Design; D019427:HIV Integrase / Q000378:metabolism*; D019428:HIV Integrase Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology; D006367:HeLa Cells; D006801:Humans; D062105:Molecular Docking Simulation; D015394:Molecular Structure
chemical_list: D047188:Chalcones; D019428:HIV Integrase Inhibitors; D019427:HIV Integrase; C514801:p31 integrase protein, Human immunodeficiency virus 1